https://www.bgi.com/global/molecular-genetics/nifty-non-invasive-prenatal-testing/nifty-pro/
For providing a more comprehensive test to mothers, NIFTY® finished her upgrade by the end of March in 2018, becoming NIFTY® pro that can test for all the chromosomal numeric aneuploidies and 84 kinds of microdeletion/duplication syndromes with four times of data size increased.
SUITABLE FOR:
pregnant women from week 10 of pregnancy |
TA TIME:
Under 10 working days |
SAMPLE:
Peripheral blood sample |
TECHNOLOGY:
Low coverage whole genome sequencing |
---|
TRISOMIES | SEX CHROMOSOME ANEUPLOIDIES | DELETION/DUPLICATION SYNDROMES INCLUDING | GENDER IDENTIFICATION |
---|---|---|---|
Down’s Syndrome (T21) | Turner Syndrome (monosomy X) | Wolf-Hirschhorn Syndrome | Male/Female |
Edwards Syndrome (T18) | Klinefelter Syndrome (XXY) | DiGeorge Syndrome | |
Patau Syndrome (T13) | Triple X Syndrome (XXX) | Miller-Dieker Syndrome | |
T22 | Jacob’s Syndrome (XYY) | Prader-Willi/Angelman Syndrome (15q11.2) | |
T16 | Williams Beuren Syndrome | ||
T9 | Smith-Magenis Syndrome | ||
Chromosome 1p36 Deletion Syndrome |
NIFTY® pro Brochure |
Over 5,000,000 tests performed worldwide. Validated by a study of nearly 146,958 pregnancies.